Edition:
United States

People: Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

1.40NOK
8 Dec 2016
Change (% chg)

-- (--)
Prev Close
kr1.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
73,313
52-wk High
kr3.25
52-wk Low
kr1.23

Framroze, Bomi 

Dr. Bomi Framroze has served as Chief Scientific Officer of Hofseth Biocare ASA since 2010. Dr. Framroze is a Discovery scientist with over 40 worldwide patents and publications in Life Science and Chemical software research. He has been an Associate Director of Chemical Discovery at American Cyanamid, an Executive Director at Gharda Chemicals Ltd. and was Founder/CSO of Row2Technologies Inc. Since 2004 he has been carrying out Discovery research in process technologies, biochemistry and marine ingredients.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --